Vanguard Personalized Indexing Management’s Cytokinetics CYTK Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $449K | Buy |
13,591
+1,509
| +12% | +$49.9K | 0.01% | 1245 |
|
|
2025
Q1 | $486K | Buy |
12,082
+5,096
| +73% | +$205K | 0.01% | 1133 |
|
|
2024
Q4 | $329K | Buy |
6,986
+305
| +5% | +$14.3K | 0.01% | 1298 |
|
|
2024
Q3 | $353K | Sell |
6,681
-1,363
| -17% | -$72K | 0.01% | 1268 |
|
|
2024
Q2 | $436K | Sell |
8,044
-638
| -7% | -$34.6K | 0.01% | 1096 |
|
|
2024
Q1 | $609K | Buy |
8,682
+3,193
| +58% | +$224K | 0.01% | 907 |
|
|
2023
Q4 | $458K | Buy |
+5,489
| New | +$458K | 0.01% | 1043 |
|